In a landmark decision, the U.S. Food and Drug Administration has cleared Essilor’s new Stellest eyeglass lenses for sale—the first FDA-cleared eyeglass lenses shown in clinical trials to slow the ...
A spectacle lens designed to slow the progression of myopia can, for the first time, be marketed as a myopia control device in the United States.
In anti-VEGF treatments, the amplitude of central subfield retinal thickness fluctuations do not appear to influence visual outcomes. The presence, but not the amplitude, of retinal thickness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback